SEC Tracker
Get the app

Biovie BIVI

Biovie reduces stock offering to $285,000

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Amendment reduces offering to $285,000
  2. Common stock listed on Nasdaq under BIVI
  3. Last sale price $1.34 per share on Nov 4, 2026
  4. Public float was $17,905,158.45 as of Nov 4, 2026

Written from the 424B5 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Biovie files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. GT Biopharma GTBP public float $9M, Jun 30, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025
  4. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  5. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.